OCUP
Ocuphire Pharma, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website ocuphire.com
- Employees(FY) 9
- ISIN US67577R1023
Performance
-14.03%
1W
-3.16%
1M
-35.93%
3M
-42.29%
6M
-44.02%
YTD
-64.53%
1Y
Profile
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate for dim light or night vision disturbances; and for pharmacologically induced mydriasis and presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. The company is headquartered in Farmington Hills, Michigan.
Technical Analysis of OCUP 2024-05-10
Overview:
In analyzing the technical indicators for OCUP stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible future stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for potential investors.
T...
Recent News & Updates
- 2024-05-10 01:53
- 2024-05-09 20:00
- 2024-05-05 20:00
- 2024-05-02 20:00
Ocuphire Pharma to Present at the Aegis Virtual Conference(Globenewswire)
- 2024-04-21 20:00
- 2024-04-10 22:03
- 2024-03-31 19:14
- 2024-03-14 23:53
- 2024-03-09 00:09
- 2024-03-07 19:00
- 2024-03-03 19:18
- 2024-02-22 19:00
- 2024-02-15 03:10
- 2024-02-13 19:00
- 2024-02-04 19:00
- 2024-01-24 03:10
- 2024-01-10 18:41
- 2024-01-03 19:00
- 2023-11-29 19:00
- 2023-11-27 03:38
- 2023-11-26 19:00
- 2023-11-12 19:00
- 2023-11-01 20:00
- 2023-11-01 04:52
- 2023-10-31 20:05
- 2023-10-25 20:00
- 2023-10-05 20:00
- 2023-09-26 20:00
- 2023-09-26 20:00
- 2023-09-10 21:41
Page 1 of 4
previousnext